RITONAVIR

CAS No.
162990-01-4 ;155213-67-5
CCD No.
CCD00180242
Formula
C37 H48 N6 O5 S2
MolWeight
720.955

Basic Information

Product Name: RITONAVIR
CAS: 162990-01-4 ;155213-67-5
English Synonyms: 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5R)-3-HYDROXY-5-[[(2S)-3-METHYL-2-[[METHYL-[(2-PROPAN-2-YL-1,3-THIAZOL-4-YL)METHYL]CARBAMOYL]AMINO]BUTANOYL]AMINO]-1,6-DIPHENYL-HEXAN-2-YL]CARBAMATE ; THIAZOL-5-YLMETHYL (2S,3S,5S)-3-HYDROXY-5-((S)-2-(3-((2-ISOPROPYLTHIAZOL-4-YL)METHYL)-3-METHYLUREIDO)-3-METHYLBUTANAMIDO)-1,6-DIPHENYLHEXAN-2-YLCARBAMATE ; NORVIR SOFTGEL ; RTV ; 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5S)-3-HYDROXY-5-[[(2S)-3-METHYL-2-[[METHYL-[(2-PROPAN-2-YL-1,3-THIAZOL-4-YL)METHYL]CARBAMOYL]AMINO]BUTANOYL]AMINO]-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE ; (3S,4S,6S,9S)-4-HYDROXY-12-METHYL-9-(1-METHYLETHYL)-13-[2-(1-METHYLETHYL)-4-THIAZOLYL]-8,11-DIOXO-3,6-BIS(PHENYLMETHYL)-2,7,10,12-TETRAAZATRIDECANOIC ACID 5-THIAZOLYLMETHYL ESTER ; ((1S,2S,4S)-1-BENZYL-2-HYDROXY-4-((S)-2-[3-(2-ISOPROPYL-THIAZOL-4-YLMETHYL)-3-METHYL-UREIDO]-3-METHYL-BUTYRYLAMINO)-5-PHENYL-PENTYL)-CARBAMIC ACID THIAZOL-5-YLMETHYL ESTER ; ABT 538 ; RITONAVIR ; 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5S)-3-HYDROXY-5-[(2S)-3-METHYL-2-([METHYL(([2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL))CARBAMOYL]AMINO)BUTANAMIDO]-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE ; NORVIR
MDL Number.: MFCD00927142
H bond acceptor: 11
H bond donor: 4
Smile: CC(C)c1nc(cs1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C[C@@H]([C@H](Cc3ccccc3)NC(=O)OCc4cncs4)O
InChi: InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1
InChiKey: InChIKey=NCDNCNXCDXHOMX-XGKFQTDJSA-N

Property

Comments: GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

Safety information

* If the product has intellectual property rights, a license granted is must or contact us.